ArticleActa neuropathologica communications2024

Atrx loss as a promising screening tool for the identification of diffuse midline glioma subtype, H3K27/MAPKinase co-altered.

Arnault Tauziède-Espariat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.